Author

Wen G Jiang

Professor, Cardiff University School of Medicine - Cited by 33,900 - cancer - metastasis - invasion - angiogenesis - surgery

Biography

Dr. Wen G. Jiang is currently a professor of surgery and tumor biology at Cardiff University School of Medicine, Cardiff, UK. He is also the Director of the Cardiff University-Peking University Joint Cancer Institute and the Academic Director of International Relations of Cardiff University. After graduated from Peking Medical School with MB BCh and completed surgical training in Peking′s hospital, he earned his MD from the University of Wales College of Medicine. He subsequently progressed his career at Cardiff to his current chair position.  
Title
Cited by
Year
Targeting hyaluronic acid and peritoneal dissemination in colorectal cancer
F Soliman, L Ye, W Jiang, R HargestClinical Colorectal Cancer 21 (2), e12-e134, 2022202
6
2022
Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone
L Sui, A Sanders, WG Jiang, L YeComputational and Structural Biotechnology Journal 20, 2745-2758, 2022202
6
2022
Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
Y Nie, F Feng, W Luo, AJ Sanders, Y Zhang, J Liang, C Chen, W Feng, ...Cancer gene therapy 29 (10), 140-1417, 2022202
5
2022
Activated leukocyte cell adhesion molecule (ALCAM), a potential ‘seed’and ‘soil’receptor in the peritoneal metastasis of gastrointestinal cancers
YM Yang, L Ye, F Ruge, Z Fang, K Ji, AJ Sanders, S Jia, C Hao, QP Dou, ...International Journal of Molecular Sciences 24 (1), 876, 20220
3
2023
Osteopontin and cancer: insights into its role in drug resistance
C Hao, J Lane, WG JiangBiomedicines 11 (1), 197, 030
2
2023
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance
L Sui, J Zeng, H Zhao, L Ye, TA Martin, AJ Sanders, F Ruge, A Jiang, ...International Journal of Oncology 6 (1), 1-16, 030
2
2023
EPLIN, a putative tumour suppressor in colorectal cancer, implications in drug resistance
J Zeng, AJ Sanders, L Ye, R Hargest, F Ruge, WG JiangInternational Journal of Molecular Sciences 3 (3), 153, 0
2
2022
ALCAM, activated leukocyte cell adhesion molecule, in clinical gastric cancer and patient’s response to chemotherapies
YM Yang, F Ruge, K Ji, S Jia, Y Jia, AJ Sanders, J Ji, WG JiangAnticancer research 43 (4), 463-475, 2023202
1
2023
Sex hormone-regulated CMG2 is involved in breast and prostate cancer progression
Z Fang, C Killick, C Halfpenny, N Frewer, KA Frewer, F Ruge, WG Jiang, ...Cancer Genomics & Proteomics 9 (6), 703-70, 2022202
1
2022
Breast Tumour Kinase (Brk/PTK6) contributes to breast tumour xenograft growth and modulates chemotherapeutic responses in vitro
RS Burmi, GM Box, U Wazir, HA Hussain, JA Davies, WJ Court, SA Eccles, ...Genes 3 (3), 402, 2022202
1
2022

Referred From: https://scholar.google.co.uk/citations?user=A0VgxQMAAAAJ&hl=en

Cited by
Citations 33900
h-index 93
i10-index 509
Recommended Journals
Open Access Journals